Filtered By:
Cancer: Squamous Cell Carcinoma

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 19645 results found since Jan 2013.

Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of Cervical Cancer
CONCLUSIONS: Serum levels of TK1, SCC-Ag, and MUC-1 show promise as biomarkers for cervical cancer diagnosis and prognosis. TK1 and SCC-Ag are elevated, while MUC-1 is decreased in cervical cancer patients. Further research is warranted to confirm these findings and explore additional biomarkers.PMID:37708549
Source: Alternative Therapies in Health and Medicine - September 14, 2023 Category: Complementary Medicine Authors: Mei Zhang Lingli Xin Bo Cheng Bin Yan Jie Zhen Chao Yang Li Ma Qingxiang Hou Source Type: research

Human parvovirus B19 infection in malignant and benign tissue specimens of different head and neck anatomical subsites
CONCLUSIONS: To sum up, B19V was frequently present in HNSCC tissues of Iranian patients but mostly absent in the adjacent non-tumor tissues as well as oral mucocele lesions, buccal, and nasopharyngeal swabs of healthy subjects. HPV possibly contributes to B19V persistence in HNSCC tissues. Additional research is required to investigate potential etiological or cofactor roles of B19V in the development of HNSCCs.PMID:37710342 | DOI:10.1186/s13027-023-00528-5
Source: Cancer Control - September 14, 2023 Category: Cancer & Oncology Authors: Haniyeh Abuei Sepide Namdari Tahereh Pakdel Fatemeh Pakdel Azadeh Andishe-Tadbir Abbas Behzad-Behbahani Mohammad J Ashraf Parnian Alavi Ali Farhadi Source Type: research

Antibiotics may interfere with nivolumab efficacy in patients with head and neck squamous cell carcinoma
CONCLUSION: Our findings indicate that antibiotic treatment significantly shortens the PFS with nivolumab therapy in patients with head and neck SCC.PMID:37708868 | DOI:10.1159/000533860
Source: Oncology - September 14, 2023 Category: Cancer & Oncology Authors: Reio Ueta Hiroo Imai Ken Saijo Yoshifumi Kawamura Shuto Kodera Keigo Komine Kota Ouchi Yuki Kasahara Sakura Taniguchi Yuya Yoshida Keiju Sasaki Hidekazu Shirota Masanobu Takahashi Chikashi Ishioka Source Type: research

Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of Cervical Cancer
CONCLUSIONS: Serum levels of TK1, SCC-Ag, and MUC-1 show promise as biomarkers for cervical cancer diagnosis and prognosis. TK1 and SCC-Ag are elevated, while MUC-1 is decreased in cervical cancer patients. Further research is warranted to confirm these findings and explore additional biomarkers.PMID:37708549
Source: Alternative Therapies in Health and Medicine - September 14, 2023 Category: Complementary Medicine Authors: Mei Zhang Lingli Xin Bo Cheng Bin Yan Jie Zhen Chao Yang Li Ma Qingxiang Hou Source Type: research

Neoadjuvant triplet chemotherapy with docetaxel, cisplatin plus 5-FU vs docetaxel, cisplatin plus S-1 for advanced esophageal squamous cell carcinoma: Propensity score matched analysis
CONCLUSIONS: Neoadjuvant DCS therapy for resectable advanced ESCC did not result in significantly higher clinical and pathological response than neoadjuvant DCF therapy. However, neoadjuvant DCS therapy for resectable ESCC required comparatively shorter hospital stays and incurred lower costs, making it an attractive therapeutic option.PMID:37708864 | DOI:10.1159/000533790
Source: Oncology - September 14, 2023 Category: Cancer & Oncology Authors: Junya Kitadani Toshiyasu Ojima Keiji Hayata Taro Goda Akihiro Takeuchi Shinta Tominaga Naoki Fukuda Tomoki Nakai Hiroki Yamaue Manabu Kawai Source Type: research

Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of Cervical Cancer
CONCLUSIONS: Serum levels of TK1, SCC-Ag, and MUC-1 show promise as biomarkers for cervical cancer diagnosis and prognosis. TK1 and SCC-Ag are elevated, while MUC-1 is decreased in cervical cancer patients. Further research is warranted to confirm these findings and explore additional biomarkers.PMID:37708549
Source: Alternative Therapies in Health and Medicine - September 14, 2023 Category: Complementary Medicine Authors: Mei Zhang Lingli Xin Bo Cheng Bin Yan Jie Zhen Chao Yang Li Ma Qingxiang Hou Source Type: research

Construction of a Diagnostic Model for Small Cell Lung Cancer Combining Metabolomics and Integrated Machine Learning
CONCLUSION: This study is the first to analyze the difference between metabolomics and lipidomics and to construct a d-model to detect SCLC using integrated machine learning. This study may be of great significance for the screening and early diagnosis of SCLC patients.PMID:37706531 | DOI:10.1093/oncolo/oyad261
Source: The Oncologist - September 14, 2023 Category: Cancer & Oncology Authors: Xiaoling Shang Chenyue Zhang Ronghua Kong Chenglong Zhao Haiyong Wang Source Type: research

Antibiotics may interfere with nivolumab efficacy in patients with head and neck squamous cell carcinoma
CONCLUSION: Our findings indicate that antibiotic treatment significantly shortens the PFS with nivolumab therapy in patients with head and neck SCC.PMID:37708868 | DOI:10.1159/000533860
Source: Oncology - September 14, 2023 Category: Cancer & Oncology Authors: Reio Ueta Hiroo Imai Ken Saijo Yoshifumi Kawamura Shuto Kodera Keigo Komine Kota Ouchi Yuki Kasahara Sakura Taniguchi Yuya Yoshida Keiju Sasaki Hidekazu Shirota Masanobu Takahashi Chikashi Ishioka Source Type: research

Neoadjuvant triplet chemotherapy with docetaxel, cisplatin plus 5-FU vs docetaxel, cisplatin plus S-1 for advanced esophageal squamous cell carcinoma: Propensity score matched analysis
CONCLUSIONS: Neoadjuvant DCS therapy for resectable advanced ESCC did not result in significantly higher clinical and pathological response than neoadjuvant DCF therapy. However, neoadjuvant DCS therapy for resectable ESCC required comparatively shorter hospital stays and incurred lower costs, making it an attractive therapeutic option.PMID:37708864 | DOI:10.1159/000533790
Source: Oncology - September 14, 2023 Category: Cancer & Oncology Authors: Junya Kitadani Toshiyasu Ojima Keiji Hayata Taro Goda Akihiro Takeuchi Shinta Tominaga Naoki Fukuda Tomoki Nakai Hiroki Yamaue Manabu Kawai Source Type: research

Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of Cervical Cancer
CONCLUSIONS: Serum levels of TK1, SCC-Ag, and MUC-1 show promise as biomarkers for cervical cancer diagnosis and prognosis. TK1 and SCC-Ag are elevated, while MUC-1 is decreased in cervical cancer patients. Further research is warranted to confirm these findings and explore additional biomarkers.PMID:37708549
Source: Alternative Therapies in Health and Medicine - September 14, 2023 Category: Complementary Medicine Authors: Mei Zhang Lingli Xin Bo Cheng Bin Yan Jie Zhen Chao Yang Li Ma Qingxiang Hou Source Type: research

Construction of a Diagnostic Model for Small Cell Lung Cancer Combining Metabolomics and Integrated Machine Learning
CONCLUSION: This study is the first to analyze the difference between metabolomics and lipidomics and to construct a d-model to detect SCLC using integrated machine learning. This study may be of great significance for the screening and early diagnosis of SCLC patients.PMID:37706531 | DOI:10.1093/oncolo/oyad261
Source: The Oncologist - September 14, 2023 Category: Cancer & Oncology Authors: Xiaoling Shang Chenyue Zhang Ronghua Kong Chenglong Zhao Haiyong Wang Source Type: research

Antibiotics may interfere with nivolumab efficacy in patients with head and neck squamous cell carcinoma
CONCLUSION: Our findings indicate that antibiotic treatment significantly shortens the PFS with nivolumab therapy in patients with head and neck SCC.PMID:37708868 | DOI:10.1159/000533860
Source: Oncology - September 14, 2023 Category: Cancer & Oncology Authors: Reio Ueta Hiroo Imai Ken Saijo Yoshifumi Kawamura Shuto Kodera Keigo Komine Kota Ouchi Yuki Kasahara Sakura Taniguchi Yuya Yoshida Keiju Sasaki Hidekazu Shirota Masanobu Takahashi Chikashi Ishioka Source Type: research

Neoadjuvant triplet chemotherapy with docetaxel, cisplatin plus 5-FU vs docetaxel, cisplatin plus S-1 for advanced esophageal squamous cell carcinoma: Propensity score matched analysis
CONCLUSIONS: Neoadjuvant DCS therapy for resectable advanced ESCC did not result in significantly higher clinical and pathological response than neoadjuvant DCF therapy. However, neoadjuvant DCS therapy for resectable ESCC required comparatively shorter hospital stays and incurred lower costs, making it an attractive therapeutic option.PMID:37708864 | DOI:10.1159/000533790
Source: Oncology - September 14, 2023 Category: Cancer & Oncology Authors: Junya Kitadani Toshiyasu Ojima Keiji Hayata Taro Goda Akihiro Takeuchi Shinta Tominaga Naoki Fukuda Tomoki Nakai Hiroki Yamaue Manabu Kawai Source Type: research